MULTIPLE SCLEROSIS IN 2010 Advances in monitoring and treatment of multiple sclerosis

被引：5
|
作者：
Filippi, Massimo [1 ,2 ]
机构：
[1] Inst Sci, Div Neurosci, Inst Expt Neurol, Neuroimaging Res Unit, I-20132 Milan, Italy
[2] Univ Hosp San Raffaele, I-20132 Milan, Italy
来源：
NATURE REVIEWS NEUROLOGY | 2011年 / 7卷 / 02期
关键词：
PLACEBO-CONTROLLED TRIAL; NEUTRALIZING ANTIBODIES; DIAGNOSTIC-CRITERIA; INTERFERON-BETA; ORAL FINGOLIMOD;
D O I：
10.1038/nrneurol.2010.215
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2010 represented a milestone in the history of multiple sclerosis monitoring and treatment. MRI and immunological biomarkers were identified to track disease evolution and, ultimately, to guide treatment decisions. moreover, oral disease-modifying therapies emerged that should increase treatment regimen adherence and improve patient outcomes.
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
  • [1] Advances in the Treatment of Multiple Sclerosis
    Goldschmidt, Carolyn
    McGinley, Marisa P.
    NEUROLOGIC CLINICS, 2021, 39 (01) : 21 - 33
  • [2] Treatment Monitoring in Multiple Sclerosis - Efficacy and Safety
    Mahmoudi, Nima
    Wattjes, Mike P.
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2024, 34 (03) : 439 - 452
  • [3] Diagnosis and treatment of multiple sclerosis
    Zavalishin, I. A.
    Peresedova, A. V.
    Stoida, N. I.
    Gur'yanova, O. E.
    Arzumanyan, N. Sh
    Alekseeva, N. S.
    Eliseeva, D. D.
    Gulevskaya, T. S.
    Bryukhov, V. V.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (06) : 89 - 96
  • [4] Treatment Update in Multiple Sclerosis
    Morris, Katrina
    Yiannikas, Con
    CURRENT ALLERGY AND ASTHMA REPORTS, 2012, 12 (03) : 246 - 254
  • [5] Corticosteroids in the treatment of multiple sclerosis
    Myhr, K. M.
    Mellgren, S. I.
    ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 : 73 - 80
  • [6] Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS)
    Stamatellos, Vasileios-Periklis
    Papazisis, Georgios
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2023, 18 (01) : 39 - 50
  • [7] Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Ingwersen, Jens
    Aktas, Orhan
    Hartung, Hans-Peter
    NEUROTHERAPEUTICS, 2016, 13 (01) : 47 - 57
  • [8] Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment
    Tur, Carmen
    Tintore, Mar
    Vidal-Jordana, Angela
    Bichuetti, Denis
    Nieto Gonzalez, Pablo
    Jesus Arevalo, Maria
    Arrambide, Georgina
    Anglada, Elisenda
    Galan, Ingrid
    Castillo, Joaquin
    Jordi Rio, Carlos Nos
    Isabel Martin, Maria
    Comabella, Manuel
    Sastre-Garriga, Jaume
    Montalban, Xavier
    PLOS ONE, 2013, 8 (12):
  • [9] Therapeutic Advances in Multiple Sclerosis
    Yang, Jennifer H.
    Rempe, Torge
    Whitmire, Natalie
    Dunn-Pirio, Anastasie
    Graves, Jennifer S.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [10] Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis
    Baldassari, Laura E.
    Fox, Robert J.
    DRUGS, 2018, 78 (15) : 1549 - 1566
12345